aromasil has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dziadziuszko, R; Jassem, J; Orłowska-Kunikowska, E; Senkus-Konefka, E | 1 |
1 other study(ies) available for aromasil and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Exacerbation of diabetes related to exemestane treatment.
Topics: Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Blood Glucose; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Middle Aged; Neoplasm Recurrence, Local; Thoracic Wall | 2008 |